Gyrodyne, LLC (GYRO) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 21, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GYRO SEC filings page.
This page shows Gyrodyne, LLC (GYRO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2014 cash consumption accompanied a FY2015 balance-sheet shift toward lower leverage, not a complete operating trend.
The key mismatch is between accounting loss and cash use: FY2014 recorded a net loss of$3.1M alongside operating cash flow of-$5.5M , indicating cash demands exceeded the reported loss. By FY2015, assets had risen to$57.9M while liabilities fell to$14.4M , pointing to a materially different financing posture even though operating results were not reported.
The 2014 loss exceeded reported revenue of
Liabilities fell from
Financial Health Signals
Gyrodyne, LLC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q2 2026.
Cash & Balance Sheet
Gyrodyne, LLC held $3.8M in cash against $10.7M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
GYRO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
GYRO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q4'2410-K | Q2'1610-K | Q1'1610-Q | Q4'1510-K | Q3'1510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $57.9M | $58.1M | $58.7M+3.6% | $56.7M | $40.9M | $57.1M | $57.9M+31.9% | $56.1M |
| Cash & Equivalents | $3.8M | $4.0M | $4.5M-23.2% | $5.9M | $4.3M | $6.2M | $5.9M+45.9% | $7.6M+74.0% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $143K | $151K | $155K-53.8% | $336K | N/A | N/A | N/A | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $30.9M | $32.2M | $32.8M+26.0% | $26.1M | $10.9M | $13.5M | $14.4M-29.3% | $9.8M |
| Long-Term Debt | $10.7M | $10.8M | $10.9M-2.7% | $11.2M | N/A | N/A | N/A | N/A |
| Total Equity | $27.1M | $25.9M | $25.9M-15.5% | $30.6M | $30.0M | $43.6M | $43.5M+85.3% | $43.9M |
Not reported in any period shown, so not listed: Current Assets, Inventory, Goodwill, Current Liabilities, Non-Current Liabilities, Retained Earnings.
GYRO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
GYRO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Gyrodyne, LLC GYRO | FY2015 | N/A | N/A | N/A | $9.9M | — |
| American Strategic Investment Co. NYC | FY2025 | N/A | -$21.2M | N/A | $18.3M | — |
| Fangdd Network Group Ltd. DUO | FY2025 | $50.7M | -$12.1M | -23.9% | $22.0M | 5/100 |
| Ohmyhome Limited OMH | FY2025 | $9.5M | -$7.2M | -75.2% | $6.4M | 2/100 |
| Wetouch Technology Inc. WETH | FY2025 | $45.1M | $7.2M | 15.9% | $12.8M | 77/100 |
Where Gyrodyne, LLC Ranks
Frequently Asked Questions
What are Gyrodyne, LLC's total assets?
Gyrodyne, LLC (GYRO) had $57.9M in total assets as of fiscal year 2015, including both current and long-term assets.
What is Gyrodyne, LLC's debt-to-equity ratio?
Gyrodyne, LLC (GYRO) had a debt-to-equity ratio of 0.33 as of fiscal year 2015, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Gyrodyne, LLC's P/E ratio?
Gyrodyne, LLC (GYRO) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $9.9M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Gyrodyne, LLC's price-to-sales ratio?
Gyrodyne, LLC (GYRO) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $9.9M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.